Dr. David Lawrence Phillips , MD
Urology โข Austin, TX
608 Radam Ln
Austin, TX 787451172
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 18, 2006; this date does not establish years in practice.
-
Published CMS data list 15,029 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0897 โ Injection, denosumab, 1 mg: 9,960 service units.
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 907 service units.
- 99214 โ Established patient outpatient office visit: 786 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 5,605 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl โ 1,031 prescription fills, including refills.
- Finasteride โ 790 prescription fills, including refills.
- Orgovyx (Relugolix) โ 587 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 41 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: 4,072. Middle half: 1,074 to 6,811.
More Medicare Part B services than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 15,673 in 2020 to 15,029 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
608 Radam Ln
Austin, TX 787451172
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Texas Medical School At San Antonio
1988
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
854 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $553,980 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $422,269 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
10,050 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$7,683,436 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $915.85 across 47 records.
By nature of payment
- Food and Beverage: $880.79 across 46 records.
- Education: $35.06 across 1 record.
Reporting-company totals (3 largest of 12)
- ABBVIE INC.: $227.51 across 10 records.
- Janssen Pharmaceuticals, Inc: $176.94 across 14 records.
- Pfizer Inc.: $126.69 across 6 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
38 years (graduated 1988)
CMS Doctors and Clinicians data list 1988 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Dr. Phillips as eligible to order or refer durable medical equipment (DME) for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Austin and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: 4,072. Middle half: 1,074 to 6,811.
More Medicare Part B services than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: $200,192. Middle half: $89,956 to $268,588.
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Austin, TX (2024, 34 clinicians with data). Median for this group: $148,342. Middle half: $66,664 to $197,998.
A higher Medicare payment amount than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Urology in Austin, TX (2024, 35 clinicians with data). Median for this group: 950. Middle half: 457 to 2,182.
More Part D prescriptions than 95% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Austin, TX (2024, 35 clinicians with data). Median for this group: $250,675. Middle half: $46,030 to $485,105.
A higher Part D drug cost than 95% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
43 active clinicians are listed under Urology with a practice address in Austin, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Austin
60.5% of these 43 clinicians have the CMS telehealth indicator.
74.4% of these 43 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services varied from year to year: 15,673 in 2020 and 15,029 in 2024.
- 2020: 15,673
- 2021: 18,126
- 2022: 13,969
- 2023: 17,718
- 2024: 15,029
-
Medicare-allowed amount
Medicare-allowed amount stayed about the same: $564,661 in 2020 and $553,980 in 2024.
- 2020: $564,661
- 2021: $649,397
- 2022: $560,458
- 2023: $615,005
- 2024: $553,980
-
Paid by Medicare
Paid by Medicare stayed about the same: $429,539 in 2020 and $422,269 in 2024.
- 2020: $429,539
- 2021: $494,522
- 2022: $419,140
- 2023: $469,101
- 2024: $422,269
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 30% from 4,303 in 2020 to 5,605 in 2024.
- 2020: 4,303
- 2021: 4,589
- 2022: 4,869
- 2023: 5,353
- 2024: 5,605
-
30-day fills
30-day fills increased 26% from 8,006 in 2020 to 10,050 in 2024.
- 2020: 8,006
- 2021: 8,526
- 2022: 9,245
- 2023: 9,834
- 2024: 10,050
-
Part D drug cost
Part D drug cost increased 125% from $3,411,595 in 2020 to $7,683,436 in 2024.
- 2020: $3,411,595
- 2021: $4,390,465
- 2022: $6,041,645
- 2023: $7,013,946
- 2024: $7,683,436
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 39% from $1,495.70 in 2021 to $915.85 in 2025.
- 2021: $1,495.70
- 2022: $1,733.10
- 2023: $1,786.13
- 2024: $1,378.48
- 2025: $915.85
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 47 records totaling $915.85.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Olympus America Inc. |
Food and Beverage
In-kind items and services
|
iTIND System | General | $38.53 |
| AstraZeneca Pharmaceuticals LP |
Education
In-kind items and services
|
IMFINZI | General | $35.06 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $28.33 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $26.97 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $26.68 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.87 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.86 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.64 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $24.52 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.33 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.33 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.33 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $24.28 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.06 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $22.97 |
| ACCORD HEALTHCARE, INC. |
Food and Beverage
In-kind items and services
|
Camcevi | General | $22.32 |
| ACCORD HEALTHCARE, INC. |
Food and Beverage
In-kind items and services
|
Camcevi | General | $21.83 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $21.83 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $21.38 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $21.28 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $21.19 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $20.98 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $20.91 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $20.91 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $20.74 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
9,960 | 38 | $48.86 | $25.41 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
907 | 591 | $48.00 | $16.03 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
786 | 485 | $249.17 | $126.74 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
684 | 120 | $95.14 | $62.29 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
546 | 13 | $209.23 | $54.22 |
|
81003
Automated urinalysis test
|
510 | 367 | $7.00 | $2.20 |
|
36415
Insertion of needle into vein for collection of blood sample
|
362 | 282 | $15.00 | $8.58 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
305 | 97 | $77.40 | $47.71 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
227 | 192 | $168.00 | $90.31 |
|
99426
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
|
171 | 34 | $82.00 | $61.85 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
120 | 19 | $2000.00 | $180.94 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
119 | 107 | $44.00 | $11.49 |
|
96401
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
|
67 | 16 | $175.00 | $72.64 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
66 | 56 | $477.00 | $241.49 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
59 | 59 | $380.00 | $164.29 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
57 | 29 | $76.00 | $35.86 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
23 | 20 | $336.00 | $178.10 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
19 | 19 | $250.00 | $110.31 |
|
51700
Simple bladder irrigation and/or instillation
|
15 | 11 | $194.00 | $74.60 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
14 | 14 | $10.00 | $3.11 |
|
76872
Ultrasound scan of pelvic region through rectum
|
12 | 12 | $250.00 | $141.32 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 1,031 | 77,090 | $16,508.39 | 330 |
| Finasteride | Finasteride | 790 | 60,655 | $10,177.83 | 234 |
| Orgovyx | Relugolix | 587 | 18,108 | $1,618,724.16 | 75 |
| Myrbetriq | Mirabegron | 381 | 16,982 | $246,993.08 | 108 |
| Prednisone | Prednisone | 331 | 10,845 | $1,883.53 | 48 |
| Abiraterone Acetate | Abiraterone Acetate | 326 | 10,260 | $705,952.97 | 46 |
| Erleada | Apalutamide | 262 | 7,980 | $3,530,172.41 | 36 |
| Cephalexin | Cephalexin | 153 | 4,868 | $1,344.43 | 87 |
| Gemtesa | Vibegron | 153 | 6,611 | $103,045.17 | 37 |
| Dutasteride | Dutasteride | 148 | 11,910 | $4,412.04 | 44 |
| Methenamine Hippurate | Methenamine Hippurate | 141 | 5,891 | $9,221.00 | 35 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 102 | 7,174 | $2,157.13 | 30 |
| Testosterone Cypionate | Testosterone Cypionate | 102 | 5,491 | $5,947.81 | 45 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 91 | 7,340 | $1,929.37 | 29 |
| Testosterone | Testosterone | 85 | 3,184 | $12,193.48 | 20 |
| Potassium Citrate Er | Potassium Citrate | 78 | 4,450 | $9,809.19 | 20 |
| Nubeqa | Darolutamide | 74 | 2,220 | $951,458.91 | 14 |
| Silodosin | Silodosin | 72 | 4,360 | $5,100.48 | 20 |
| Mirabegron Er | Mirabegron | 71 | 4,830 | $47,312.47 | 32 |
| Bicalutamide | Bicalutamide | 70 | 3,382 | $2,215.48 | 16 |
| Estradiol | Estradiol | 55 | 3,636 | $3,796.75 | 32 |
| Levofloxacin | Levofloxacin | 52 | 193 | $96.57 | 43 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 1,051 | $150.50 | 20 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 51 | 2,430 | $3,148.89 | 14 |
| Tramadol Hcl | Tramadol Hcl | 47 | 252 | $121.89 | 38 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-11-01NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Doctor of Nursing Practice, Advanced Practice Registered Nurse, Family Nurse Practitioner (Certified)
Clinical Nurse Specialist
AGCNSBC
Urology
Doctor of Medicine (M.D.)
Occupational Therapist
Occupational Therapist Registered
Physical Therapist
Physical Therapist, Doctor of Physical Therapy
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 608 RADAM LN, AUSTIN, TX 787451172 (Tel: 5124435988)
Registered at 8240 N MOPAC EXPY STE 100, AUSTIN, TX 787598869 (Tel: 5126871950)
Recorded as DAVID PHILLIPS, MD
Registered at 8240 N MOPAC EXPY, STE 100, AUSTIN, TX 787598869 (Tel: 5126871970)
NPI status registered as active in NPPES database
Registered at 4007 JAMES CASEY ST, C150, AUSTIN, TX 787453369 (Tel: 5124435988)
Registered at 1020 W 34TH ST, AUSTIN, TX 787052009 (Tel: 5126871950)
Recorded as DAVID PHILLIPS, M.D.
Urology (license number reported to NPPES: TX H337)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Austin
- Dr. Brett Baker, MD
- Dr. J Wolf, MD
- Dr. Varun Sundaram, MD
- Dr. David Dalton, MD
- Dr. Michael Floyd, MD
- Dr. Edward Osterberg, MD
Mailing Address
8240 N Mopac Expy Ste 100
Austin, TX 787598869
Phone: 5126871950